On Wednesday, RBC Capital Markets adjusted its stance on Sartorius Stedim (EPA:STDM) Biotech (DIM:FP) (OTC:SDMHF), downgrading the stock from Outperform to Sector Perform and reducing the price ...

RBC’s new price target for Sartorius Stedim is €240 per share, based on a multiple of 21x its estimated 2027 EBITDA. This reflects a more conservative valuation compared to the premium ...

=----- Sartorius Stedim Biotech S.A. - 13400 Aubagne, France DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Article L 233-8-II of the Code of commerce ...

We are transferring coverage of Sartorius AG and its subsidiary Sartorius Stedim Biotech—both active in biopharmaceutical equipment and laboratory consumables—to a new analyst. Sartorius ...

On Wednesday, RBC Capital Markets adjusted its stance on Sartorius Stedim (EPA:STDM) Biotech (DIM:FP) (OTC:SDMHF), downgrading the stock from Outperform to Sector Perform and reducing the price target ...

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell ...

The life science group Sartorius launches the new Octet ® R8e biolayer interferometry (BLI) system, providing researchers with its most advanced detection capabilities to date for real-time ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sartorius Stedim Biotech S.A. + Watchlist DIM FR Open Last Updated: May 27, 2025 4:40 p.m. CEDT Delayed quote ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...